Aclaris Therapeutics (ACRS) Return on Assets (2017 - 2025)
Historic Return on Assets for Aclaris Therapeutics (ACRS) over the last 9 years, with Q3 2025 value amounting to 0.8%.
- Aclaris Therapeutics' Return on Assets fell 5700.0% to 0.8% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.8%, marking a year-over-year decrease of 5700.0%. This contributed to the annual value of 0.63% for FY2024, which is 2400.0% down from last year.
- Per Aclaris Therapeutics' latest filing, its Return on Assets stood at 0.8% for Q3 2025, which was down 5700.0% from 0.71% recorded in Q2 2025.
- In the past 5 years, Aclaris Therapeutics' Return on Assets registered a high of 0.21% during Q2 2021, and its lowest value of 0.8% during Q3 2025.
- Its 5-year average for Return on Assets is 0.42%, with a median of 0.35% in 2024.
- In the last 5 years, Aclaris Therapeutics' Return on Assets skyrocketed by 3100bps in 2024 and then crashed by -5700bps in 2025.
- Aclaris Therapeutics' Return on Assets (Quarter) stood at 0.35% in 2021, then increased by 1bps to 0.34% in 2022, then fell by -30bps to 0.45% in 2023, then tumbled by -49bps to 0.67% in 2024, then decreased by -20bps to 0.8% in 2025.
- Its Return on Assets was 0.8% in Q3 2025, compared to 0.71% in Q2 2025 and 0.64% in Q1 2025.